History
U.S. Pharmacist is a magazine and website that focuses on providing pharmacists with up-to-date information on various medical topics, including pain management, women’s health, infectious diseases, and respiratory diseases. The website offers articles, continuing education (CE) lessons, and treatment plans tailored to healthcare professionals.
According to its
[About page](https://www.uspharmacist.com/about), “U.S. Pharmacist is a monthly journal dedicated to providing the nation’s pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry, and academia.” [Read our profile on the United States media and government.](https://mediabiasfactcheck.com/united-states-media-profile/)
Funded by / Ownership
[WebMD](https://mediabiasfactcheck.com/webmd/) owns and publishes U.S. Pharmacist. Advertising, print subscriptions, and paid CE exams, priced at $7.95 per exam or $69 for 12 lessons, generate revenue.
Analysis / Bias
In review, U.S. Pharmacist provides articles and CE lessons that are generally well-researched and sourced. Topics covered include “Managing Pediatric Pain,” “The Role of Pharmacotherapy in Endometriosis,” and “Respiratory Syncytial Virus Infection in Infants and Young Children.” Articles are usually written by healthcare professionals and are targeted towards pharmacists.
Articles and headlines are low-biased and fact-based, such as this
[Artificial Intelligence Might Streamline Drug Development](https://www.uspharmacist.com/article/artificial-intelligence-might-streamline-drug-development). There is no evidence of the promotion of pseudoscience as all information provided appears to be evidence-based and in line with mainstream medical advice.
Failed Fact Checks
- None in the Last 5 years.